|
|
D |
2025-08-26 13:46:59 UTC |
- Amount To Be Raised
- $43,999,930
- Associated Brokers / Dealers
- N/A
- CIK Number
- 0001901628
- Filed Document
- 0001901628-25-000003
- Exclusions or Exemptions
- 506b
- Accepted Date
- 2025-08-26 13:46:59 UTC
- Type of Offering
- D
- Industry
- Biotechnology
- Principal Place of Business
- TEXAS
- Revenue or Assets
- Decline to Disclose
- Type of Security
- Equity
|
|
|
D |
2024-05-29 12:52:51 UTC |
- Amount To Be Raised
- $42,999,962
- Associated Brokers / Dealers
- N/A
- CIK Number
- 0001901628
- Filed Document
- 0001901628-24-000001
- Exclusions or Exemptions
- 506b
- Accepted Date
- 2024-05-29 12:52:51 UTC
- Type of Offering
- D
- Industry
- Biotechnology
- Principal Place of Business
- TEXAS
- Revenue or Assets
- Decline to Disclose
- Type of Security
- Equity
|
|
|
D |
2022-09-07 15:40:04 UTC |
- Amount To Be Raised
- $10,000,000
- Associated Brokers / Dealers
- N/A
- CIK Number
- 0001901628
- Filed Document
- 0001901628-22-000006
- Exclusions or Exemptions
- 506b
- Accepted Date
- 2022-09-07 15:40:04 UTC
- Type of Offering
- D
- Industry
- Biotechnology
- Principal Place of Business
- NEW YORK
- Revenue or Assets
- Decline to Disclose
- Type of Security
- Equity
|
|
|
D/A |
2022-09-07 15:37:14 UTC |
- Amount To Be Raised
- $26,999,944
- Associated Brokers / Dealers
- N/A
- CIK Number
- 0001901628
- Filed Document
- 0001901628-22-000005
- Exclusions or Exemptions
- 506b
- Accepted Date
- 2022-09-07 15:37:14 UTC
- Type of Offering
- D/A
- Industry
- Biotechnology
- Principal Place of Business
- NEW YORK
- Revenue or Assets
- Decline to Disclose
- Type of Security
- Equity
|
|
|
D |
2022-01-11 14:59:09 UTC |
- Amount To Be Raised
- $19,999,947
- Associated Brokers / Dealers
- N/A
- CIK Number
- 0001901628
- Filed Document
- 0001901628-22-000002
- Exclusions or Exemptions
- 506b
- Accepted Date
- 2022-01-11 14:59:09 UTC
- Type of Offering
- D
- Industry
- Biotechnology
- Principal Place of Business
- NEW YORK
- Revenue or Assets
- Decline to Disclose
- Type of Security
- Equity
|